levonorgestrel has been researched along with drospirenone in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.17) | 18.2507 |
2000's | 10 (21.74) | 29.6817 |
2010's | 33 (71.74) | 24.3611 |
2020's | 2 (4.35) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Hampton, AL; Nie, G; Salamonsen, LA | 1 |
Emans, SJ; Pettinato, A | 1 |
Suthipongse, W; Taneepanichskul, S | 1 |
Sangthawan, M; Taneepanichskul, S | 1 |
Bray, JA; Bray, JD; Brown, EL; Ghatge, R; Horwitz, KB; Jacobsen, BM; Jelinsky, S; Lyttle, CR; Richer, JK; Saraf, K; Tunkey, C; Winneker, RC | 1 |
Shulman, LP | 1 |
Claeys, S; De Bodt, M; Van Cauwenberge, P; Van Lierde, KM | 1 |
Tan, JK | 1 |
Bertina, RM; Dahm, AE; Helmerhorst, FM; Rosendaal, FR; Rosing, J; Sandset, PM; van Vliet, HA | 1 |
Goller, S; Länge, R; Maser, E; Steger-Hartmann, T; Vonk, R; Zeilinger, J | 1 |
Cremer, M; Jacobs, A; Phan-Weston, S | 1 |
Assmann, A; Dinger, J; Minh, TD; Möhner, S | 1 |
Bressler, B; Brophy, JM; Delaney, JA; Etminan, M | 1 |
Hernandez, RK; Jick, SS; Parkin, L; Sharples, K | 1 |
Hernandez, RK; Jick, SS | 1 |
Heinemann, K; Heinemann, LA | 1 |
Lidegaard, Ø; Løkkegaard, E; Nielsen, LH; Skjeldestad, FE; Skovlund, CW | 1 |
Reid, RL | 1 |
Voelker, R | 1 |
Bird, ST; Brophy, JM; Delaney, JA; Etminan, M; Liu, X; Pepe, SR | 1 |
Jick, S; Pennap, D | 1 |
Helmerhorst, FM; Kaptein, AA; Lopez, LM | 1 |
Bird, ST; Bressler, B; Brophy, JM; Delaney, JA; Etminan, M; Liu, W | 1 |
Bird, ST; Brophy, JM; Delaney, JA; Etminan, M; Hartzema, AG | 1 |
Coelingh Bennink, HJ; Ebes, F; Fauser, BC; Wouters, W; Zimmerman, Y | 1 |
Kostev, K; Rashed, AN; Ziller, M; Ziller, V | 1 |
de Bastos, M; Dekkers, OM; Helmerhorst, FM; Rosendaal, FR; Stegeman, BH; Stijnen, T; Van Hylckama Vlieg, A | 1 |
El-Haggar, SM; Mostafa, TM | 1 |
Avar, P; Lovas, S; Maasz, G; Pirger, Z; Svigruha, R; Takács, P; Takátsy, A; Tóth, LG; Zrinyi, Z | 1 |
Coelingh Bennink, HJ; Foidart, JM; Klipping, C; Maillard, C; Mawet, M; Zimmerman, Y | 1 |
Appels, N; Coelingh Bennink, HJ; Duijkers, IJ; Foidart, JM; Jost, M; Klipping, C; Maillard, C; Mawet, M; Zimmerman, Y | 1 |
Dinger, J; Heinemann, K; Möhner, S | 1 |
Apter, D; Beekman, L; Coelingh Bennink, HJ; Foidart, JM; Maillard, C; Mawet, M; Zimmerman, Y | 1 |
Abenhaim, HA; Eberg, M; Eisenberg, MJ; Filion, KB; Joseph, L; Larivée, N; Suissa, S | 1 |
Fodor, I; Kiss, T; Lovas, S; Maasz, G; Pirger, Z; Takacs, P; Zrinyi, Z | 1 |
Cagnacci, A | 1 |
Coulombe, J; Filion, KB; Larivée, N; Suissa, S; Tagalakis, V | 1 |
Abe, J; Fukuda, A; Hane, Y; Hasegawa, S; Hatahira, H; Hirade, K; Kinosada, Y; Matsui, T; Motooka, Y; Naganuma, M; Nakamura, M; Sasaoka, S; Takahashi, Y | 1 |
Bachelot, A; Dureau, P; Funck-Brentano, C; Germain, M; Hulot, JS; Lebourgeois, B; Salem, JE; Trégouët, DA; Voiriot, P | 1 |
Hugon-Rodin, J; Plu-Bureau, G; Sabbagh, E | 1 |
Adeyanju, OA; Olatunji, LA | 1 |
Bastidas, A; Duijkers, I; Foidart, JM; Jost, M; Klipping, C; Maillard, C; Mawet, M | 1 |
Dogné, JM; Douxfils, J; Foidart, JM; Gaspard, U; Jost, M; Morimont, L | 1 |
6 review(s) available for levonorgestrel and drospirenone
Article | Year |
---|---|
A review of drospirenone for safety and tolerability and effects on endometrial safety and lipid parameters contrasted with medroxyprogesterone acetate, levonorgestrel, and micronized progesterone.
Topics: Androstenes; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menopause; Progesterone; Women's Health | 2006 |
New developments in hormonal therapy for acne.
Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel | 2007 |
Recent innovations in oral contraception.
Topics: Acne Vulgaris; Androstenes; Contraception; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Estradiol; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperkalemia; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Ovulation; Pregnancy; Randomized Controlled Trials as Topic; Thromboembolism; Uterine Hemorrhage | 2010 |
Oral contraceptives containing drospirenone for premenstrual syndrome.
Topics: Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Premenstrual Syndrome; Randomized Controlled Trials as Topic | 2012 |
Combined oral contraceptives: venous thrombosis.
Topics: Androstenes; Contraceptives, Oral, Combined; Cyproterone; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Pulmonary Embolism; Randomized Controlled Trials as Topic; Venous Thrombosis | 2014 |
Hormonal contraception: venous and arterial disease.
Topics: Adult; Androstenes; Atherosclerosis; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Middle Aged; Risk Factors; Venous Thromboembolism | 2017 |
7 trial(s) available for levonorgestrel and drospirenone
Article | Year |
---|---|
An open-label randomized comparative study of oral contraceptives between medications containing 3 mg drospirenone/30 microg ethinylestradiol and 150 microg levonogestrel/30 microg ethinylestradiol in Thai women.
Topics: Adolescent; Adult; Androstenes; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Thailand | 2004 |
A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 microg on premenstrual symptoms.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Regression Analysis; Treatment Outcome | 2005 |
The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive.
Topics: Adult; Analysis of Variance; Androstenes; Contraceptives, Oral, Combined; Cross-Over Studies; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Double-Blind Method; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Prospective Studies; Testosterone | 2013 |
Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives.
Topics: Adolescent; Adult; Alkaline Phosphatase; Androstenes; Aspartate Aminotransferases; Cholesterol, HDL; Cholesterol, LDL; Collagen Type I; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estetrol; Estrogens; Ethinyl Estradiol; Female; gamma-Glutamyltransferase; Growth Hormone; Humans; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Levonorgestrel; Lipid Metabolism; Liver; Mineralocorticoid Receptor Antagonists; Osteocalcin; Peptides; Sex Hormone-Binding Globulin; Triglycerides; Young Adult | 2015 |
Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Endometrium; Estetrol; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Mineralocorticoid Receptor Antagonists; Ovarian Follicle; Ovulation; Ovulation Inhibition; Pilot Projects; Pituitary Gland; Progesterone; Ultrasonography; Young Adult | 2015 |
Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA).
Topics: Androstenes; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Estetrol; Estradiol; Female; Humans; Levonorgestrel; Metrorrhagia; Nandrolone | 2016 |
Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone.
Topics: Androstenes; Contraceptives, Oral, Combined; Estetrol; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Sex Hormone-Binding Globulin | 2021 |
33 other study(ies) available for levonorgestrel and drospirenone
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Progesterone analogues similarly modulate endometrial matrix metalloproteinase-1 and matrix metalloproteinase-3 and their inhibitor in a model for long-term contraceptive effects.
Topics: Adult; Androstenes; Cells, Cultured; Collagenases; Contraceptive Agents, Female; Endometrium; Female; Humans; Levonorgestrel; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Pregnenediones; Progesterone; Progesterone Congeners; Stromal Cells; Tissue Inhibitor of Metalloproteinase-1 | 1999 |
New contraceptive methods: update 2003.
Topics: Adolescent; Androstenes; Contraception; Contraceptive Agents; Contraceptive Devices; Contraceptive Devices, Female; Female; Guidelines as Topic; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; World Health Organization | 2003 |
Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells.
Topics: Alkaline Phosphatase; Androstenes; Breast Neoplasms; Cell Line, Tumor; Cluster Analysis; Desogestrel; Dose-Response Relationship, Drug; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Levonorgestrel; Ligands; Medroxyprogesterone Acetate; Oligonucleotide Array Sequence Analysis; Progesterone; Progestins; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA; Transcription, Genetic | 2005 |
Response of the female vocal quality and resonance in professional voice users taking oral contraceptive pills: a multiparameter approach.
Topics: Adult; Androstenes; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Norpregnenes; Phonation; Speech Acoustics; Voice; Voice Disorders; Voice Quality | 2006 |
Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor.
Topics: Activated Protein C Resistance; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipoproteins; Middle Aged; Protein S; Thrombophilia | 2008 |
Effects of synthetic gestagens on fish reproduction.
Topics: Androstenes; Animals; Cyprinidae; Female; Gonads; Levonorgestrel; Male; Reproduction; Sperm Motility | 2009 |
Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Germany; Humans; Levonorgestrel; Logistic Models; Middle Aged; Mineralocorticoid Receptor Antagonists; Nandrolone; Risk Factors; Venous Thromboembolism; Young Adult | 2010 |
Oral contraceptives and the risk of gallbladder disease: a comparative safety study.
Topics: Adult; Androstenes; Cholecystectomy; Confidence Intervals; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Gallbladder Diseases; Humans; Levonorgestrel; Progestins; Proportional Hazards Models; Retrospective Studies; Risk; Risk Factors | 2011 |
Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.
Topics: Adolescent; Adult; Age Distribution; Androstenes; Case-Control Studies; Contraceptives, Oral; Contraceptives, Oral, Combined; Estrogens; Female; Humans; Levonorgestrel; Risk Factors; United Kingdom; Venous Thromboembolism; Young Adult | 2011 |
Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data.
Topics: Adolescent; Adult; Age Distribution; Androstenes; Case-Control Studies; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Risk Factors; United States; Venous Thromboembolism; Young Adult | 2011 |
Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel.
Topics: Androstenes; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Mineralocorticoid Receptor Antagonists; Risk Assessment; Venous Thromboembolism | 2011 |
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.
Topics: Adolescent; Adult; Androstenes; Anticoagulants; Cohort Studies; Confounding Factors, Epidemiologic; Contraceptives, Oral; Denmark; Desogestrel; Dose-Response Relationship, Drug; Epidemiologic Methods; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Mineralocorticoid Receptor Antagonists; Norpregnenes; Pregnancy; Time Factors; Venous Thromboembolism; Young Adult | 2011 |
Oral contraceptives and venous thromboembolism: pill scares and public health.
Topics: Aged; Androstenes; Case-Control Studies; Contraceptives, Oral, Combined; Fear; Female; Humans; Levonorgestrel; Middle Aged; Prospective Studies; Public Health; Retrospective Studies; Risk Factors; Venous Thromboembolism | 2011 |
Risk of blood clots higher for oral contraceptives with certain progestins.
Topics: Androstenes; Contraceptives, Oral; Cyproterone; Denmark; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Progestins; Registries; Risk; Venous Thromboembolism | 2011 |
The association between drospirenone and hyperkalemia: a comparative-safety study.
Topics: Adult; Androstenes; Cohort Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Hyperkalemia; Levonorgestrel; Logistic Models; Proportional Hazards Models; Retrospective Studies; Risk Factors; Spironolactone | 2011 |
Drospirenone- and levonorgestrel-containing oral contraceptives and the risk of gallbladder disease.
Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Cholecystectomy; Cholecystitis; Contraceptives, Oral; Databases, Factual; Female; Gallbladder Diseases; Humans; Levonorgestrel; Middle Aged; Mineralocorticoid Receptor Antagonists; Odds Ratio; Risk Factors; United Kingdom | 2012 |
Irritable bowel syndrome and drospirenone-containing oral contraceptives; a comparative-safety study.
Topics: Adolescent; Adult; Androstenes; Cohort Studies; Contraceptives, Oral, Combined; Databases, Factual; Female; Humans; Incidence; Irritable Bowel Syndrome; Levonorgestrel; Middle Aged; Mineralocorticoid Receptor Antagonists; Proportional Hazards Models; Retrospective Studies; Young Adult | 2012 |
Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?
Topics: Adolescent; Adult; Androstenes; Cohort Studies; Contraceptives, Oral; Databases, Factual; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Proportional Hazards Models; Risk; Time Factors; United States; Venous Thromboembolism; Young Adult | 2013 |
The prescribing of contraceptives for adolescents in German gynecologic practices in 2007 and 2011: a retrospective database analysis.
Topics: Adolescent; Androstenes; Child; Chlormadinone Acetate; Contraceptive Agents; Desogestrel; Drug Prescriptions; Drug Utilization; Female; Germany; Gynecology; Humans; Levonorgestrel; Menstruation Disturbances; Practice Patterns, Physicians'; Pregnancy; Pregnancy in Adolescence; Retrospective Studies | 2013 |
Drospirenone: more cases of thrombosis than with levonorgestrel.
Topics: Adolescent; Adult; Androstenes; Child; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Middle Aged; Thrombosis | 2013 |
Cardiovascular risk in Egyptian healthy consumers of different types of combined oral contraceptives pills: A comparative study.
Topics: Adiponectin; Adipose Tissue; Adult; Androstenes; Anthropometry; Cardiovascular Diseases; Chemistry, Pharmaceutical; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Cross-Sectional Studies; Drug Combinations; Egypt; Ethinyl Estradiol; Female; Humans; Leptin; Levonorgestrel; Norpregnenes; Resistin; Risk Factors | 2015 |
HPLC-MS/MS analysis of steroid hormones in environmental water samples.
Topics: Androstenes; Chromatography, High Pressure Liquid; Environmental Monitoring; Fresh Water; Levonorgestrel; Limit of Detection; Progesterone; Solid Phase Extraction; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2016 |
Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives.
Topics: Adult; Androstenes; Cardiovascular Diseases; Cohort Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Europe; Female; Follow-Up Studies; Humans; Incidence; Levonorgestrel; Longitudinal Studies; Mineralocorticoid Receptor Antagonists; Patient Reported Outcome Measures; Pharmacovigilance; Progestins; Proportional Hazards Models; Risk Factors | 2016 |
Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study.
Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Contraceptives, Oral, Combined; Drug Administration Schedule; Female; Humans; Levonorgestrel; Middle Aged; Risk Factors; United Kingdom; Venous Thromboembolism; Young Adult | 2017 |
Complex molecular changes induced by chronic progestogens exposure in roach, Rutilus rutilus.
Topics: Androstenes; Animals; Biomarkers; Brain; Cyprinidae; Ecosystem; Environmental Exposure; Europe; Female; Gonads; Kidney; Lakes; Levonorgestrel; Lipids; Liver; Progesterone; Progestins; Protein Deglycase DJ-1; Receptors, LDL; Vitellogenins; Water Pollutants, Chemical | 2017 |
Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.
Topics: Adolescent; Adult; Androstenes; Cohort Studies; Contraceptives, Oral, Combined; Drug Administration Schedule; Female; Humans; Levonorgestrel; Middle Aged; Proportional Hazards Models; Risk Factors; Venous Thromboembolism; Young Adult | 2017 |
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Androstenes; Child; Contraceptives, Oral, Combined; Databases, Factual; Desogestrel; Drug-Related Side Effects and Adverse Reactions; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Levonorgestrel; Male; Middle Aged; Norethindrone; Norgestrel; Odds Ratio; Progestins; Thromboembolism; Young Adult | 2017 |
Association of Oral Contraceptives With Drug-Induced QT Interval Prolongation in Healthy Nonmenopausal Women.
Topics: Administration, Oral; Adult; Androgen Antagonists; Androstenes; Cohort Studies; Contraceptive Agents, Female; Desogestrel; Europe; Female; Humans; Levonorgestrel; Logistic Models; Long QT Syndrome; Norpregnenes; Sotalol; Young Adult | 2018 |
[Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
Topics: Androstenes; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Female; France; Humans; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Vascular Diseases; Venous Thromboembolism | 2018 |
Drospirenone-containing oral contraceptives do not affect glucose regulation and circulating corticosterone.
Topics: Androstenes; Animals; Blood Glucose; Body Weight; Contraceptives, Oral; Corticosterone; Drug Combinations; Ethinyl Estradiol; Female; Insulin; Insulin-Secreting Cells; Levonorgestrel; Rats | 2019 |
Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone.
Topics: Contraceptives, Oral, Combined; Estetrol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Thrombin | 2022 |